Bernstein analyst Lee Hambright raised the firm’s price target on Tandem Diabetes (TNDM ... as part of a broader research note indicating that the firm is positive on 2025 for the MedTech ...

Kidney function declined among yo-yo dieters, and they also were more likely to have increased levels of the protein albumin ...

Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

SAB-142 shows favorable safety and pharmacodynamic activity in Phase 1 trial, advancing to Phase 2b for type 1 diabetes. SAB BIO announced positive results from its Phase 1 trial of SAB-142 ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...

Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes ...